Multimodal nanovectors with a theranostic potential for cancer treatment - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Communication Dans Un Congrès Année : 2015

Multimodal nanovectors with a theranostic potential for cancer treatment

Résumé

Targeted theranosis (diagnosis combined to therapy) strategies are intended to improve cancer treatment efficacy while decreasing side effects. Nanovectors of hybrid (organic/inorganic) structure allow to combine multiple physical and biological functions and thus are being developed as promising contrast agents for multimodal diagnosis and drug nanocarriers for therapy of cancers. We present here three types of theranostic nanovectors our group develops, all based on combination of magnetic and optical properties with biological targeting and anticancer activity. Development of these nanovectors is being made in the frame of a multidisciplinary research, including biotechnology, chemical synthesis, pharmaceutical technology, physico-chemical and biological analysis in vitro and in vivo. The rational design of our nanovectors has been confirmed by complementary techniques as leading to promising biocompatibility and theranostic potential.
Fichier principal
Vignette du fichier
ACTES-RITS2015-HALp14-15.pdf (87.06 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01143905 , version 1 (20-04-2015)

Licence

Paternité

Identifiants

  • HAL Id : inserm-01143905 , version 1
  • PRODINRA : 312749

Citer

Ambre Carrouée, Christophe Alric, Stephanie David, Katel Hervé-Aubert, Nicolas Aubrey, et al.. Multimodal nanovectors with a theranostic potential for cancer treatment. Journées RITS 2015, Mar 2015, Dourdan, France. p14-15. ⟨inserm-01143905⟩
457 Consultations
234 Téléchargements

Partager

Gmail Facebook X LinkedIn More